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Abstract
Purpose Since the incidental discovery and systematic introduction of mechanical endovascular stroke treatment in 2015
there are few reports about the real-life situation in daily clinical practice. The aim of this study was to evaluate the
mechanical thrombectomy data documented in the quality assurance database of the German Society for Interventional
Radiology and Minimally Invasive Therapy (DeGIR) and the German Society of Neuroradiology (DGNR) in 2019.
Methods We retrospectively analyzed the clinical and procedural data of all mechanical thrombectomies that were
entered into the voluntary nationwide database in 2019. The information of each procedure was provided on a standardized
web-based data sheet. Data were exported and analyzed by a group of experts on behalf of the DGNR.
Results A total of 13,840 data sets from 158 participating centers could be analyzed. Mean age of the patients was
74± 13 years; 53.9% were female. Vessel occlusion was located in the anterior circulation in 87.4%, in the posterior
circulation in 10.7%. On hospital admission, the median National Institutes of Health Stroke Scale (NIHSS) was 14
(lower/upper quartile 10/19); at hospital discharge, median NIHSS had dropped to 9 (lower/upper quartile 2/12; p<0.001).
Recanalization of the occluded vessel segment was successful (TICI 2b+ 3) in 88.4%. The reported complication rate was
7.3%, with subarachnoid hemorrhage as the most frequent complication (3.4%), followed by parenchymal hemorrhage
(1.7%) and embolization in new territories (1.2%).
Overall, the median time interval from symptom onset to hospital admission was 94min (quartiles 59/180min), the median
time from hospital admission to groin puncture was 74min (lower/upper quartile 47/103min), and the median duration of
the procedure 43min (lower/upper quartile 25.2/73.2 min). A comparison between primary and secondary referral revealed
a significant faster symptom-to-intervention time for primary referrals, whereas in-house workflows showed no significant
difference.
Availability of Data and Material Detailed information of each
procedure was provided by the participating interventional centers
in a web-based format and sent to the DeGIR database using
both symmetric and asymmetric encoding techniques to ensure
anonymization of the records. Data were analyzed by members of
the DeGIR on behalf of the German Society of Neuroradiology
(DGNR).
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Conclusion The analysis represents the largest documented cohort of acute stroke patients treated by thrombectomy. The
documentation allows for a detailed evaluation of procedural, clinical, logistic and radiation exposure data and might be
used for monitoring the quality of the treatment on a nationwide scale.
Keywords Thrombectomy · Stroke · Quality assurance · Database · Stroke logistics
Introduction
In 2012 the German Society for Neuroradiology (DGNR)
started a nationwide registry to document the safety and
quality of neuroradiological interventions, divided into ves-
sel-opening (module E) and vessel-occluding (module F)
procedures of the extracranial and intracranial supra-aortic
vasculature. Both modules were embedded into the registry
of the German Society for Interventional Radiology and
Minimally Invasive Therapy (DeGIR) documenting inter-
ventions in general radiology (modules A–D) since 2005.
The main goal of the web-based voluntary national reg-
istry is to monitor the number and quality of the differ-
ent interventional procedures; however, with an increasing
number of participating sites all over Germany and solitary
centers in Austria and Switzerland [1], the registry offers
a close look at real-life data of these procedures and a dif-
ferent perspective in addition to rigorous clinical trial. This
is especially true for thrombectomy as the frequency of
this procedure increased in a short period of time following
the publication of landmark multicenter studies that proved
a high effectiveness of endovascular stroke therapy in 2015
[2–8]. The endovascular treatment option thus became an
evidence-based treatment for severe ischemic stroke (Na-
tional Institutes of Health Stroke Scale [NIHSS] ≥6 for
stroke in the anterior circulation) and has been accord-
ingly recommended in several national and international
guidelines [9, 10]. The practice patterns in Germany and
Austria are generally in line with the European guidelines
for thrombectomy [11], which have been endorsed by the
DGNR [12].
The aim of this study was to analyze the mechanical
thrombectomy data documented in the German DeGIR/DGNR
database in 2019 in order to understand the efficacy of the
nationwide acute stroke therapy in large vessel occlusion.
Methods
Study Design and Ethical Approval
We retrospectively analyzed the clinical and procedural data
of all mechanical thrombectomies that were entered into
the voluntary, nationwide database in 2019. Detailed infor-
mation of each procedure was provided by the participating
interventional centers in a web-based format and sent to the
DeGIR database using both symmetric and asymmetric en-
coding techniques to ensure anonymization of the records.
Data were exported and analyzed by members of the DeGIR
(S.R., W.W., P.S.) on behalf of the DGNR. The study pro-
tocol and data analysis were approved by the local ethics
committee of the University of Münster (No. 2020-420-f-
S).
Data Extraction and Statistical Analysis
Anonymized records from the database in module E, sub-
category “Endovascular Stroke Treatment”, were exported
in an Excel chart. Data sheets were analyzed if the treatment
had been performed between 1 January 2019 (00:00h) and
31 December 2019 (24:00h). Columns with time specifica-
tions, e.g. “start of symptoms” or “start of interventions”,
were controlled for entry errors and revised in cases of un-
reasonable or negative time intervals. This may occur when
the beginning of symptoms or the treatment was before
midnight and the end of the procedure was after midnight.
Data exploration was performed by a professional statis-
tician using primarily descriptive statistics for categorical
and noncategorical variables. Groups were compared by
Kruskal-Wallis rank sum test for general differences. Post
hoc tests between groups were done by pairwise Wilcoxon
rank sum tests with p-values adjusted by the false discov-
ery rate procedure. An alpha level of 0.05 was considered
significant.
Parameters
Table 1 gives an overview about the evaluated parameters
which could be assigned to a clinical, logistic and interven-
tional category. In order to keep the data entry as simple
and fast as possible, single items were defined as nonobli-
gatory, e.g. ASPECTS (Alberta Stroke Program Early CT
Score) on admission. Clinical long-term follow-up is vol-
untary since follow-up visits are currently not reimbursed
and mandatory visits would lead to potential legal conflicts
with insurance companies and hospitals. Thus, a mandatory
request would lower the motivation of interventional sites
to participate in the data collection.
Frequencies of variables were expressed as absolute and
relative numbers, and mean values with standard deviation.
Due to the wide range of time intervals between logistic
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Table 1 Overview of clinical, logistical and interventional parameters
of the DeGIR database for acute endovascular stroke treatment
(module E). Valid and missing/invalid data sets of the respective items






Gender, age Y 13,840 0
NIHSS on admission Y 13,840 0









IV-lysis Y 13,840 0
Logistic parameters
Start of symptoms Y 13,840 0
Time of hospital ad-
mission
Y 13,840 0
Start IV-lysis N 13,840 0
Start Intervention Y 13,840 0
End Intervention Y 13,469 371
(2.7%)
Interventional parameters







Complications Y 13,840 0
Fluoroscopy time Y 13,603 237
(1.7%)
Dose area product Y 13,608 232
(1.7%)
NIHSS National Institutes of Health Stroke Scale, ASPECTS Alberta
Stroke Program Early CT Score, IV intravenous, TICI thrombolysis in
Cerebral Infarction
Fig. 1 Changes in NIHSS from
admission to discharge in 8609
complete data sets




ICA—cervical segment 529 (4.6)
ICA—petrous/cavernous segment 626 (5.5)
ICA—intradural segment 1906 (16.6)
M1 2801 (24.5)







Subclavian artery/brachiocephalic trunk 6 (0.05)
ICA internal carotid artery, M1/2 segments of the middle cerebral
artery, ACA anterior cerebral artery, V1–4 segments of the vertebral
artery, BA basilar artery, PCA posterior cerebral artery
time points, these values were given as median with quartile
deviation.
Results
Diagnostic and Clinical Assessment
A total of 13,840 data sets from 158 clinical sites/hospitals
could be analyzed, 59 (34.3%) hospitals had entered less
than 50 data sets, 72 (45.6%) had entered 51–150, and 27
(17.1%) more than 150 data sets. Mean age of the patients
was 74± 13 years (median 77 years, lower/upper quartile
66/84), 53.9% were female, and 46.1% were male. Vessel
occlusion was located in the anterior circulation in 87.4%,
in the posterior circulation in 10.7%, and in multiple lo-
calizations in 1.9%. A detailed overview about the local-
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Fig. 2 Time intervals from the start of symptoms to the start of the intervention. The figure on the left gives the median ±lower/upper quartile, and
range for primary referrals, secondary referrals, and in-house stroke on a logarithmic scale. The figure on the right shows the relative frequency of
the three sub-groups on a time scale
ization of occluded vessel segments is given in Table 2.
Nomination of multiple occluded vessel segments was al-
lowed. This resulted in relatively high numbers for single
locations, e.g. petrous and intradural ICA (internal carotid
artery) segments.
Stratification of the patients was performed with multi-
modal computed tomography (CT) in the vast majority of
the cases: In 95% of the cases stroke imaging was done with
cranial CT and CT-angiography. Additional CT perfusion
and/or magnetic resonance imaging (MRI) was performed
in 49% and 8%, respectively. The ASPECTS was available
in only 34% of all data sets, because this variable was not
a mandatory field in 2019. Of the patients 44% received
IV thrombolysis prior to thrombectomy; in 39.7% of the
patients the onset of symptoms was not documented.
On hospital admission, the median NIHSS was 14
(lower/upper quartile 10/19). At hospital discharge, data
Table 3 Logistic time intervals by allocation type: primary referral= 8153; secondary referral= 4693; in-house stroke= 994. Data are expressed as
median (± quartiles)
Primary referral Secondary referral In-house stroke P1 P2
Start of symptoms to hospital admission [min] 70.2 (50–113) 180.0 (122–240) – 0.001 –
Start of symptoms to start IV-lysis [min] 96.0 (75–133) 95.5 (70–135) 60.0 (30–90) 0.225 0.001
Start of symptoms to start intervention [min] 160.2 (125–210) 235.0 (185–3000) 115.0 (80–165) 0.001 0.001
Hospital admission to start IV-lysis [min] 30.0 (20–40) 29.0 (15–41) – 0.013 –
Hospital admission to start intervention [min] 79.8 (60–105) 54.0 (33–90) – 0.001 –
Start IV-lysis to start intervention [min] 52.2 (48–74) 130.0 (93–172) 55.0 (33–90) 0.001 0.249
Start intervention to final pass [min] 43.2 (24–71) 43.2 (25–74) 46.0 (26–75) 0.066 0.049
P1= Statistical comparison between primary and secondary referral
P2= Statistical comparison between primary referral and in-house-stroke
were available only in 62% of the cases as this item was not
a mandatory field: median NIHSS had dropped to 9 (lower/
upper quartile 2/12; p<0.001); 64.2% of the patients had
an NIHSS score ≤8. Fig. 1 shows the changes in NIHSS in
8609 complete data sets.
Logistic Parameters
Detailed logistic time intervals for primary referral, sec-
ondary referral, and in-house stroke are given in Table 3.
Overall, the median time interval from symptom onset
to hospital admission was 94min (lower/upper quartile
59/180min), the time from hospital admission to groin
puncture was 74min (lower/upper quartile 47/103min).
With respect to in-hospital workflow, the overall median
time interval from admission to the start of IV-lysis (cor-
responding to the moment, when imaging diagnostic was
K
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Fig. 3 Final TICI score after
thrombectomy in 13,840 cases
Table 4 Type and absolute/relative frequency of procedure related
complications. Multiple entries were possible
N (%)
Total number of complications 1008 (7.3)
Embolization in new territories 234 (1.2)
Parenchymal hemorrhage 263 (1.7)
Subarachnoid hemorrhage 465 (3.4)




finished) was 30min (lower/upper quartile 19.8/40.2min),
the median time intervals from IV-lysis to the start of the
intervention (groin puncture) and the duration of the proce-
dure were 69min (lower/upper quartile 43.2/120min) and
43min (lower/upper quartile 25.2/73.2min), respectively.
A comparison between primary and secondary referral
revealed a significant faster hospital admission-to-interven-
tion time for secondary referrals (median time 79.8min
versus 54.0min, p= 0.001); however, that did not compen-
sate for the longer overall time from symptom onset-to-
intervention that was about 75min longer in the secondary
compared to the primary referral subgroup (Table 3, Fig. 2).
In-house workflows otherwise showed no significant time
differences between the subgroups.
Interventional Quality Scores and Adverse Events
Fig. 3 shows the distribution of the final TICI score after
thrombectomy. A successful recanalization of the occluded
vessel segment (TICI 2b+ 3) was documented in 88.4%,
with a first pass rate of 39.9%. Additional extracranial or
intracranial stenting was performed in 8.9% and 3.4%, re-
spectively. A combination of extracranial and intracranial
stenting was reported in 0.3% of the cases.
A detailed overview about the frequency of procedure
related complications is given in Table 4. Overall, the
reported complication rate was 7.3%, with subarachnoid
hemorrhage as the most frequent complication (3.4%), fol-
lowed by parenchymal hemorrhage (1.7%), and extracranial
or intracranial vessel dissection (1.6%). Parenchymal and/or
subarachnoid hemorrhage were symptomatic in 1.6%. The
rate of embolization in new territories was 1.2%. The me-
dian fluoroscopy time was 20min (lower/upper quartile
12/35) with a median dose area product of 7.56cGy*cm2
(lower/upper quartile 4.01/12.89). The frequency of fluo-
roscopy time and the dose area product is given in Fig. 4.
Discussion
Since the initial publication of randomized trials on me-
chanical thrombectomy in 2015, interventional stroke treat-
ment has matured as the treatment of choice in patients
with acute occlusion of large cerebral vessels [5]. Since
then numerous technical and interventional modifications
of the technology were introduced, and enormous efforts
have been undertaken both in clinical and scientific set-
tings to advance endovascular techniques, e.g. to address
more peripheral occlusion, to define the best interventional
setting, or to extend the time-dependent indications [13].
Besides these technical and clinical concerns, a major issue
remains the distribution and availability of centers that can
provide endovascular stroke treatment 24/7 in order to of-
fer modern stroke service on a nationwide basis; however,
there is currently little information about the availability
and quality of endovascular stroke treatment in a real-life
scenario as a national service approach.
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Fig. 4 Frequencies of fluo-
roscopy time (a) distribution
of the dose area product (b) in
13,840 cases
The presented data provide the currently largest and
the most coherent information about comprehensive na-
tional endovascular stroke treatment in a western country.
With nearly 14,000 voluntary documented cases in 2019,
the database not only offers detailed clinical and technical
information about endovascular stroke treatment, but also
gives a depiction about safety aspects, radiation exposure,
and—perhaps one of the most important issues—about lo-
gistic time intervals for patients with primary and secondary
referral.
Compared to the results of the large randomized stroke
trials, the reported technical results from our national
database are similar. Bush et al. analyzed the pooled data
of 1284 patients who were treated in 5 controlled stent-
retriever trials (MR CLEAN, ESCAPE, EXTEND-IA,
SWIFT PRIME, and REVASCAT) [14]. In contrast to
our cohort, patients in the endovascular group (n= 634)
were younger than in our study (65–71 years versus
74± 13 years), had a lower proportion of females (46.4%
versus 53.9%), and a somewhat higher mean NIHSS on
admission (16–17 versus 14). The lower baseline NIHSS
in our cohort might be explained in part by the higher
proportion of patients who underwent thrombectomy de-
spite a low NIHSS on admission; 21.1% of the patients
in our registry had a baseline NIHSS ≤8. This is contrary
to randomized controlled trials, where patients with low
NIHSS (<8) were mainly excluded [4, 7, 14].
As RCT patients were highly selected (only occlusions
in the anterior circulation within a 6–8h time window were
included), the proportion of IV t-PA was higher (83%)
compared to our cohort (44%). The relatively low rate of
patients that received IV t-PA in our national documen-
tation might be a consequence of a meanwhile extended
time window for endovascular stroke treatment; in 39.7%
of the patients the symptom onset was unknown or unavail-
able. Moreover, it might reflect the wider indication for
thrombectomy in a real-world scenario, when thrombec-
tomy remains the only treatment option for patients who
have contraindications for intravenous lysis, e.g. anticoag-
ulation, recent surgery or known malignancies.
The rate of successful recanalization (TICI 2b or 3) was
lower in the meta-analysis (80.4% versus 88.4%). This
K
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might be explained in part by the overestimation of the
angiographic results in a self-reporting database; however,
our results are comparable to the recanalization rates of the
EXTEND-IA and the SWIFT-Prime trials with 86.2% and
83%, respectively [4, 7]. In contrast to preceding trials that
included several recanalization techniques and devices, only
stent-retriever technology and/or aspiration catheters were
used for endovascular stroke treatment, resulting in higher
recanalization rates than in preceding trials. Procedure-re-
lated complications were reported in 6.0–8.3%, mainly em-
bolization into new territories. The reported complication
rate in our database was 7.3%.
Thus, gender data and procedural results of our database
seem to be reasonable and robust. This applies even more
to the presented logistic and fluoroscopic data as these
parameters are derived from objective measurements. So
far, there is only very little information about such logis-
tic parameters from treatment studies of acute ischemic
stroke. Bush et al. reported mean onset-to-groin punc-
ture times (200–269min) and onset-to-reperfusion times
(241–355min) for the pooled analysis of the 5 RCT. These
results are comparable to our data (Table 3), but they do not
allow for a detailed evaluation. In contrast, the complete
depiction of the logistic process in acute stroke treatment,
divided into primary and secondary referral as well as in-
house stroke is one of the strongest aspects of the presented
data. Our data confirm recent findings of regional registries
that direct referral to a comprehensive stroke center leads
to better outcome compared to secondary referral in stroke
patients [15]. It allows for in-depth analysis of external
and in-house process analysis for all kinds of subgroups.
For instance, it gives detailed information of logistic time
intervals between primary and secondary referrals, e.g.
indicating that the mean time from symptom onset to the
start of the intervention is about 75min later in secondary
referrals (Table 3). These findings can help in the discus-
sion about stroke logistics in urban and more rural areas
and—together with technical parameters like fluoroscopy
time and dose—might be used as a helpful quality marker
for the participating centers in the future [16].
Limitations
The main limitation of the presented data is that data entry
was not supervised by any means as in randomized con-
trolled trials. Monitoring data entry or checking data entry
is beyond the scope of national professional societies. Fur-
thermore, the national health system does not allow for an
elegant patient follow-up since digital national records are
not available. Thus, the robustness of the data cannot be
assessed.
When the specific registry was initiated in 2012 the main
goal was to collect clinical and procedural data from all Ger-
man interventional sites in order to get an almost complete
overview of the procedures. As the participation of the sites
is voluntary, the number of items is limited with the entry of
particular items defined as optional, e.g. the ASPECTS of
the initial CT, in order to keep data entry as simple and fea-
sible as possible. Moreover, clinical items such as vascular
risk factors and comorbidities are currently not collected.
This limits the interpretation of our data, especially when
regarding subgroups of indications, logistic parameters or
clinical outcome data. From a scientific point of view this
concept leads to a loss of robustness and quality of the col-
lected data, especially in comparison to data of controlled
clinical studies. To overcome this limitation, the selection of
the collected items is monitored and up-dated annually by
members of the quality assurance program working group
of the DeGIR/DGNR board.
Another limitation is the current lack of long-term fol-
low-up data, especially the clinical outcome at 90 days after
treatment. This issue has been discussed intensively when
starting the nationwide database and was waived due to
practical reasons since follow-up visits are currently not
reimbursed; however, as the database is continuously im-
proved, the concern of long-term data might be added in
the future, depending on changes within the healthcare sys-
tem and IT structure.
Perspective
The continuous development of the nationwide database
with its high number of recorded cases bears several areas
of interest: The data might even provide a more detailed
insight in the quality of endovascular stroke centers and
might be used for clinical research on special topics, e.g.
the effectiveness and safety of thrombectomy in stroke sub-
groups, logistic or radiation parameters, or the comparison
of high-volume and low-volume centers.
Moreover, it can be used for monitoring the treatment
quality, both on a general nationwide scale, when compar-
ing the actual results with preceding years, and on an indi-
vidual basis for each participating center, when comparing
the own results with the nationwide average results and of
course the outcomes of randomized controlled trials.
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